Limitations, agreements, and source contact

αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies · Source last updated 2020-07-20

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

point Of Contact

email

stadtermanbm@upmc.edu

organization

UPMC Hillman Cancer Center

phone

412-647-5554

title

Barbara Stadterman, MPH, MCCR, Regulatory Supervisor, CRS

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice